Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

NIH Director: Alzheimer's a huge priority for us

Eli Lilly's weight loss drug almost eliminates the risk of diabetes in overweight adults

Eli Lilly is the best stock in pharma: Trader

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

Eli Lilly CEO on the company's Q2 earnings and core business performance